SA
APNHY logo
Aspen Pharmacare Holdings Limited(APNHY)
Closing price · checked 5:15 PM ETAbout this dataData status
$10.15▲0.05 (0.50%)
Extended:$10.15+0.00 (+0.00%)· 5:15 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Aspen Pharmacare Holdings Limited (APNHY)

R&D Expenses

R 0.00

TTM · Period ending: · ZAR

APNHY logo

APNHY R&D Expenses

Latest reportedR 0.00 ZAR
APNHY FY R&D Expenses · ZAR (R 0.00 → R 0.00)
High-resolution chart · PNG

What is r&d expenses?

Research and development spending.

APNHY r&d expenses history

Annual fiscal periods · ZAR. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Aspen Pharmacare Holdings Limited R&D Expenses — Annual fiscal periods (ZAR)
Period endingR&D Expenses (ZAR)Change
0—
0−100.00%
162,000,000−24.30%
214,000,000−50.58%
433,000,000+66.54%
260,000,000+33.33%
195,000,000−7.58%
211,000,000+6,933.33%
3,000,000−98.40%
188,000,000−6.00%
200,000,0000.00%
200,000,000+275.23%
53,300,000+24.53%
42,800,000—
0—
0—
0—
0—
0—
0—
0—
0—
0—
0—

Frequently asked questions: APNHY r&d expenses

What is Aspen Pharmacare Holdings Limited (APNHY)'s current r&d expenses?

Aspen Pharmacare Holdings Limited (APNHY)'s latest reported r&d expenses (TTM) is R 0.00 as of Jun 30, 2026. Research and development spending.

How much historical r&d expenses data is available for APNHY?

Stock Alarm Pro provides 24 dated annual fiscal periods observations for Aspen Pharmacare Holdings Limited (APNHY)'s r&d expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare APNHY's r&d expenses to peers or set an alert?

You can open APNHY's r&d expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on APNHY delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.